Posts by Michael K. Mansour, MD, PhD
-
Mass General Launching Randomized, Controlled Trial of Tocilizumab for COVID-19
Tocilizumab, a monoclonal antibody that blocks IL-6 already approved in the U.S., might be effective against COVID-19, researchers from Massachusetts General Hospital believe.
